Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TAM”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01124695
What this trial is testing

Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer

Who this might be right for
Breast CancerStage IV Breast Cancer
ECOG-ACRIN Cancer Research Group 124
Large-scale testing (Phase 3)UnknownNCT02132000
What this trial is testing

Efficacy and Tolerability of Toremifene or Tamoxifen Therapy in Premenopausal Estrogen and Progesterone Receptor Positive Breast Cancer Patients

Who this might be right for
Breast Cancer Patients in PremenopausalEstrogen and/or Progesterone Receptor Positive
Fengxi Su 3,036
Not applicableEnded earlyNCT00899197
What this trial is testing

Tamoxifen Resistance in Women With Stage I, Stage II, Stage IIIA, or Stage IIIB Breast Cancer

Who this might be right for
Breast Cancer
Wake Forest University Health Sciences 2
Early research (Phase 1)Study completedNCT04080297
What this trial is testing

Dose Escalation Study in Female Subjects With Breast Cancer Receiving Aromatase Inhibitor or Tamoxifen

Who this might be right for
Vasomotor Symptoms (VMS)
Que Oncology 21
Not applicableStudy completedNCT01331057
What this trial is testing

Bilingualism: Validation Of "Avicenne's Elal"

Who this might be right for
Language
Assistance Publique - Hôpitaux de Paris 125
Large-scale testing (Phase 3)Study completedNCT00301457
What this trial is testing

Different Durations of Adjuvant Anastrozole Therapy After 2 to 3 Years Tamoxifen Therapy in Breast Cancer

Who this might be right for
Breast Cancer
Maastricht University Medical Center 1,914
Testing effectiveness (Phase 2)Temporarily pausedNCT00738777
What this trial is testing

Pre-operative Hormonal Treatment for Hormone Receptor Positive Breast Cancer

Who this might be right for
Breast Cancer
The Netherlands Cancer Institute 250
Testing effectiveness (Phase 2)Study completedNCT00295100
What this trial is testing

Tamoxifen-MRI Study

Who this might be right for
Breast Cancer
University of Pennsylvania 78
Large-scale testing (Phase 3)Study completedNCT00053898
What this trial is testing

Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy

Who this might be right for
Breast Cancer
NSABP Foundation Inc 3,104
Large-scale testing (Phase 3)UnknownNCT02914158
What this trial is testing

Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women

Who this might be right for
Breast Cancer
First Affiliated Hospital, Sun Yat-Sen University 680
Large-scale testing (Phase 3)UnknownNCT01064635
What this trial is testing

Letrozole in Treating Breast Cancer in Postmenopausal Women With Stage I, II, or III Breast Cancer Previously Treated With Tamoxifen (GIM4)

Who this might be right for
Breast Cancer
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 2,056
Early research (Phase 1)Study completedNCT01273168
What this trial is testing

Endoxifen in Adults With Hormone Receptor Positive Solid Tumors

Who this might be right for
Hormone Receptor-Positive BreastGynecologicDesmoid+1 more
National Cancer Institute (NCI) 40
Not applicableStudy completedNCT00897091
What this trial is testing

S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and Fluorouracil

Who this might be right for
Breast Cancer
SWOG Cancer Research Network 750
Large-scale testing (Phase 3)Study completedNCT00000529
What this trial is testing

Tamoxifen Study

Who this might be right for
Cardiovascular DiseasesCoronary DiseaseHeart Diseases+2 more
NSABP Foundation Inc
Large-scale testing (Phase 3)Study completedNCT03354039
What this trial is testing

Tamoxifen in Duchenne Muscular Dystrophy

Who this might be right for
Duchenne Muscular Dystrophy
University Hospital, Basel, Switzerland 93
Early research (Phase 1)UnknownNCT04961632
What this trial is testing

Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376

Who this might be right for
Breast Cancer
National Cancer Centre, Singapore 75
Early research (Phase 1)UnknownNCT02513849
What this trial is testing

Tamoxifen in Patients With Oesophageal Cancer

Who this might be right for
CancerGastrointestinal Neoplasms
University of Nottingham 20
Not applicableWithdrawnNCT00083044
What this trial is testing

Ductal Lavage in Assessing Women With Early Breast Cancer or at High Risk of Developing Breast Cancer and Who Are Eligible For Tamoxifen Therapy

Who this might be right for
Breast Cancer
Northwestern University
Early research (Phase 1)Looking for participantsNCT06320990
What this trial is testing

Chemoprevention With Tamoxifen in Pre-Invasive Pancreas Mucinous Cystic Neoplasms Not Undergoing Immediate Resection

Who this might be right for
Pancreatic CystPancreatic Mucinous Cystic Neoplasm
University of Nebraska 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT02890082
What this trial is testing

Preservation of Fertility by Ovarian Stimulation Associated With Tamoxifen, Prior Chemotherapy for Breast Cancer

Who this might be right for
Breast Cancer
Institut Cancerologie de l'Ouest 102
Next Page